|

ACT Lung Health Intervention: Phase Two

RECRUITINGN/ASponsored by Dana-Farber Cancer Institute
Actively Recruiting
PhaseN/A
SponsorDana-Farber Cancer Institute
Started2025-11-04
Est. completion2026-11-30
Eligibility
Age18 Years – 100 Years
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →

NCT06945120

Summary

This study aims to test a counseling and educational program designed to improve lung health through smoking cessation for Chinese and Korean American smokers at high risk for lung cancer.

Eligibility

Age: 18 Years – 100 YearsHealthy volunteers accepted
Inclusion Criteria:

* Self-identify as either Chinese or Korean
* Speak either Korean, Mandarin, or English
* Are 18 years of age or older
* Are current smokers (i.e., have smoked at least 100 traditional cigarettes ever and have smoked at least one traditional cigarette within the prior 30 days)
* Will live in the United States for the next 12 months

Exclusion Criteria:

* Hospitalization due to a serious mental illness (e.g., psychotic disorders) during the prior 6 months.
* We will not include any of the following special populations:

  * Adults unable to consent.
  * Adults younger than 50 or older than 80 years
  * Individuals who are not yet adults (infants, children, teenagers)
  * Pregnant women
  * Prisoners

Conditions7

CancerLung CancerSmoking (Tobacco) AddictionSmoking BehaviorsSmoking CessationSmoking, CigaretteSmoking, Tobacco

Locations2 sites

Dana-Farber Cancer Institute
Boston, Massachusetts, 02115
Mary Cooley, PhD617-632-5096Mary_cooley@dfci.harvard.edu
University of Massachusetts-Boston
Boston, Massachusetts, 02125
Sun Kim, PhD, RNsun.kim@umb.edu

Browse More Trials

Cancer trialsLung Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.